Yendou

Yendou Provides a Clinical Operations Automation Platform to Accelerate Operational Efficiency in Clinical Trials. Since its launch in March 2023, the company has quickly gained attention and adoption from over 1,200 clinicians across 46 countries/regions. Following this success, Yendou has opened its platform to pharmaceutical companies in a closed beta version. The product enables pharmaceutical and biotechnology companies to seamlessly connect, select, and onboard clinical trial sites for Phase II and Phase III oncology trials.